THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 101 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $3,059,000 | -14.5% | 210,644 | +20.2% | 0.00% | -25.0% |
| Q1 2021 | $3,578,000 | +213.9% | 175,293 | +173.3% | 0.00% | +300.0% |
| Q4 2020 | $1,140,000 | +20.3% | 64,128 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $948,000 | -44.9% | 64,128 | -15.5% | 0.00% | -75.0% |
| Q2 2018 | $1,721,000 | -41.5% | 75,900 | -37.5% | 0.00% | -42.9% |
| Q1 2018 | $2,944,000 | +42.4% | 121,400 | +112.7% | 0.01% | -12.5% |
| Q3 2016 | $2,068,000 | +57.5% | 57,074 | 0.0% | 0.01% | +60.0% |
| Q2 2016 | $1,313,000 | +4.5% | 57,074 | -28.6% | 0.01% | -16.7% |
| Q1 2016 | $1,256,000 | -4.1% | 79,900 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $1,310,000 | +121.3% | 79,900 | +48.2% | 0.01% | +100.0% |
| Q3 2015 | $592,000 | -46.9% | 53,900 | +54.1% | 0.00% | -40.0% |
| Q2 2014 | $1,115,000 | – | 34,970 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 10,898,879 | $264,297,000 | 23.51% |
| Foundation Asset Management, LP | 399,537 | $9,689,000 | 3.59% |
| Cormorant Asset Management, LP | 1,300,000 | $31,525,000 | 2.35% |
| Baupost Group | 9,309,168 | $225,747,000 | 2.18% |
| Old West Investment Management, LLC | 109,320 | $2,651,000 | 1.53% |
| SENZAR ASSET MANAGEMENT, LLC | 187,856 | $4,555,000 | 1.44% |
| Chescapmanager LLC | 350,631 | $8,503,000 | 1.27% |
| Virtus ETF Advisers LLC | 32,989 | $800,000 | 0.69% |
| Rock Springs Capital Management LP | 652,600 | $15,826,000 | 0.68% |
| NJ State Employees Deferred Compensation Plan | 34,142 | $828,000 | 0.15% |